The potential impact of the fetal genotype on maternal blood pressure during pregnancy

Journal of Hypertension

Volumn 32, Issue 8, 2014, Pages 1553-1561

  Petry, Clive J ^a   Beardsall, Kathryn ^a,b   Dunger, David B ^a,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

genetics; gestational hypertension; imprinted; preeclampsia

Indexed keywords

BECKWITH WIEDEMANN SYNDROME; BIRTH WEIGHT; BLOOD PRESSURE; CDKN1C GENE; CESAREAN SECTION; DELIVERY; DOWN SYNDROME; ENVIRONMENTAL FACTOR; FEMALE; FETUS; FETUS GROWTH; GCM1 GENE; GENE; GENE MUTATION; GENETIC RISK; GENETIC VARIABILITY; GENOME ANALYSIS; GENOME IMPRINTING; GENOTYPE; HELLP SYNDROME; HERITABILITY; HETEROZYGOTE; HUMAN; HYDRAMNIOS; HYPERTENSION; IMMUNOLOGICAL TOLERANCE; INTRAUTERINE GROWTH RETARDATION; MATERNAL BLOOD PRESSURE; MATERNAL HYPERTENSION; NONHUMAN; PLACENTA; PREECLAMPSIA; PREGNANCY; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; PROGENY; PROTEINURIA; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STOX1 GENE; TRISOMY 13; TRISOMY 21; VAGINA BLEEDING; WILD TYPE; ANIMAL; GENETICS; MOUSE;

ANIMALS; BLOOD PRESSURE; FEMALE; FETUS; GENOTYPE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; MICE; PREGNANCY;

EID: 84904045525     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000212     Document Type: Review

References (110)

1. Salonen Ros H, Lichtenstein P, Lipworth L, Cnattingius S. Genetic effects on the liability of developing preeclampsia and gestational hypertension. Am J Med Genet 2000; 91:256-260. (Pubitemid 30191247)
2. Williams PJ, Broughton Pipkin F. The genetics of preeclampsia and other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 2011; 25:405-417.
3. Basson J, Simino J, Rao DC. Between candidate genes and whole genomes: time for alternative approaches in blood pressure genetics. Curr Hypertens Rep 2012; 14:46-61.
4. Cnattingius S, Reilly M, Pawitan Y, Lichtenstein P. Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: A population-based Swedish cohort study.AmJ Med Genet A 2004; 130A:365-371. (Pubitemid 39441611)
5. Petry CJ, Ong KK, Dunger DB. Does the fetal genotype affect maternal physiology during pregnancy? Trends Mol Med 2007; 13:414-421. (Pubitemid 47562308)
6. Baergen RN. The placenta as witness. Clin Perinatol 2007; 34:393-407. (Pubitemid 47336957)
7. Benirschke K, Burton GJ, Baergen RN. Macroscopic features of a delivered fetus. Pathology of the human placenta. 6th ed. Heidelberg: Springer Verlag; 2012. pp. 13-15.
8. Gielen M, Lindsey PJ, Derom C, Loos RJ, Derom R, Nijhuis JG, et al. Curves of placental weights of live-born twins. Twin Res Hum Genet 2006; 9:664-672. (Pubitemid 44622035)
9. Almog B, Shehata F, Aljabri S, Levin I, Shalom-Paz E, Shrim A. Placenta weight percentile curves for singleton and twins deliveries. Placenta 2011; 32:58-62.
10. Sibai BM, Hauth J, Caritis S, Lindheimer MD, MacPherson C, Klebanoff M, et al. Hypertensive disorders in twin versus singleton gestations. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 2000; 182:938-942.
11. Chittacharoen A, Wetchapruekpitak S, Suthutvoravut S. Pregnancy induced hypertension in twin pregnancy. J Med Assoc Thai 2005; 88 (suppl 2):S69-S74.
12. Day MC, Barton JR, O'Brien JM, Istwan NB, Sibai BM. The effect of fetal number on the development of hypertensive conditions of pregnancy. Obstet Gynecol 2005; 106:927-931. (Pubitemid 41532896)
13. Toivanen P, Hirvonen T. Sex ratio of newborns: preponderance of males in toxemia of pregnancy. Science 1970; 170:187-188.
14. López-Llera M. Eclampsia and fetal sex. Int J Gynaecol Obstet 1990; 33:211-213. (Pubitemid 20288687)
15. Naeye RL, Demers LM. Differing effects of fetal sex on pregnancy and its outcome. Am J Med Genet Suppl 1987; 3:67-74.
16. Campbell DM, MacGillivray I, Carr-Hill R, Samphier M. Fetal sex and preeclampsia in primigravidae. Br J Obstet Gynaecol 1983; 90:26-27.
17. Di Renzo GC, Rosati A, Sarti RD, Cruciani L, Cutuli AM. Does fetal sex affect pregnancy outcome? Gend Med 2007; 4:19-30. (Pubitemid 46917064)
18. Hsu CD, Witter FR. Fetal gender effect on preterm and term preeclamptic pregnancies. Int J Gynaecol Obstet 1994; 47:53-54. (Pubitemid 24292426)
19. Sanchez AR, Macho JE, Estrada HV, Gonzalez AL. Does the gender of the fetus determine the severity of preeclampsia-eclampsia? Ginecol Obstet Mex 1996; 64:18-20.
20. Basso O, Olsen J. Sex ratio and twinning in women with hyperemesis or preeclampsia. Epidemiology 2001; 12:747-749. (Pubitemid 33134538)
21. Elsmén E, Källén K, Marsál K, Hellström-Westas L. Fetal gender and gestational-age-related incidence of preeclampsia. Acta Obstet Gynecol Scand 2006; 85:1285-1291. (Pubitemid 44601034)
22. Rueness J, Vatten L, Eskild A. The human sex ratio: effects of maternal age. Hum Reprod 2012; 27:283-287.
23. Aliyu MH, Salihu HM, Lynch O, Alio AP, Marty PJ. Fetal sex and differential survival in preeclampsia and eclampsia. Arch Gynecol Obstet 2012; 285:361-365.
24. Khalil MM, Alzahra E. Fetal gender and pregnancy outcomes in Libya: A retrospective study. Libyan J Med 2013; 8:20008.
25. Shiozaki A, Matsuda Y, Satoh S, Saito S. Impact of fetal sex in pregnancy-induced hypertension and preeclampsia in Japan. J Reprod Immunol 2011; 89:133-139.
26. Shiozaki A, Matsuda Y, Satoh S, Saito S. Comparison of risk factors for gestational hypertension and preeclampsia in Japanese singleton pregnancies. J Obstet Gynaecol Res 2013; 39:492-499.
27. Hsu CD, Johnson TR, Witter FR. Fetal gender effect on preeclampsia: A retrospective study of Baltimore area in the United States of America. Int J Gynaecol Obstet 1994; 45:160-161. (Pubitemid 24154085)
28. Sykes SD, Pringle KG, Zhou A, Dekker GA, Roberts CT, Lumbers ER. Fetal sex and the circulating renin-angiotensin system during early gestation in women who later develop preeclampsia or gestational hypertension. J Hum Hypertens 2014; 28:133-139.
29. Makhseed M, Musini VM, Ahmed MA. Association of fetal gender with pregnancy-induced hypertension and preeclampsia. Int J Gynaecol Obstet 1998; 63:55-56. (Pubitemid 28493407)
30. Hocher B, Chen YP, Schlemm L, Burdack A, Li J, Halle H, et al. Fetal sex determines the impact of maternal PROGINS progesterone receptor polymorphism on maternal physiology during pregnancy. Pharmacogenet Genomics 2009; 19:710-718.
31. Barrette VF, Adams MA, Croy BA. Endometrial decidualization does not trigger the blood pressure decline of normal early pregnancy in mice. Biol Reprod 2012; 86:66.
32. Ahmed A, Singh J, Khan Y, Seshan SV, Girardi G. A new mouse model to explore therapies for preeclampsia. PLoS One 2010; 5:e13663.
33. Davisson RL, Hoffmann DS, Butz GM, Aldape G, Schlager G, Merrill DC, et al. Discovery of a spontaneous genetic mouse model of preeclampsia. Hypertension 2002; 39:337-342. (Pubitemid 34165145)
34. Sharkey LC, McCune SA, Yuan O, Lange C, Fray J. Spontaneous pregnancy-induced hypertension and intrauterine growth restriction in rats. Am J Hypertens 2001; 14:1058-1066. (Pubitemid 32978080)
35. Sharkey LC, Kirchain S, McCune SA, Simpson GI, Archambault EZ, Boatright NK, et al. Progesterone increases blood pressure in spontaneous gestational hypertension in rats. Am J Hypertens 2005; 18:36-43 (Pubitemid 40187347)
36. Wangler MF, Chang AS, Moley KH, Feinberg AP, Debaun MR. Factors associated with preterm delivery in mothers of children with Beckwith-Wiedemann syndrome: A case cohort study from the BWS registry. Am J Med Genet A 2005; 134A:187-191. (Pubitemid 40446215)
37. Irving I. Exomphalos with macroglossia: A study of 11 cases. J Pediatr Surg 1967; 2:499-507.
38. Lage JM. Placentomegaly with massive hydrops of placental stem villi, diploid DNA content and fetal omphaloceles. Possible association with Beckwith-Wiedemann syndrome. Hum Pathol 1991; 22:591-597.
39. McCowan LM, Becroft DM. Beckwith-Wiedemann syndrome, placental abnormalities, and gestational proteinuric hypertension. Obstet Gynecol 1994; 83:813-817. (Pubitemid 24154841)
40. Choufani S, Shuman C, Weksberg R. Molecular findings in Beckwith-Wiedemann syndrome. Am J Med Genet C Semin Med Genet 2013; 163:131-140.
41. Romanelli V, Belinchón A, Campos-Barros A, Heath KE, Garcá-Miñaur S, Martínez-Glez V, et al. CDKN1C mutations in HELLP/ preeclamptic mothers of Beckwith-Wiedemann Syndrome (BWS) patients. Placenta 2009; 30:551-554.
42. Zhang J, Christianson RE, Torfs CP. Fetal trisomy 21 and maternal preeclampsia. Epidemiology 2004; 15:195-201. (Pubitemid 40416974)
43. Defant J, Gambello MJ, Monga M, Langlois PH, Noblin SJ, Vidaeff AC. Fetal trisomy 21 and the risk of preeclampsia. J Matern Fetal Neonatal Med 2010; 23:55-59.
44. Pidoux G, Gerbaud P, Cocquebert M, Segond N, Badet J, Fournier T, et al. Human trophoblast fusion and differentiation: lessons from trisomy 21 placenta. Placenta 2012; 33 (suppl):S81-S86.
45. Boyd PA, LindenbaumRH, Redman C. Preeclampsia and trisomy 13: A possible association. Lancet 1987; 2:425-427.
46. Tuohy JF, James DK. Preeclampsia and trisomy 13. Br J Obstet Gynaecol 1992; 99:891-894.
47. Bower C, Stanley F, Walters BN. Preeclampsia and trisomy 13 (letter). Lancet 1987; 2:1032.
48. Feinberg RF, Kliman HJ, Cohen AW. Preeclampsia, trisomy 13, and the placental bed. Obstet Gynecol 1991; 78:505-508.
49. Boyd PA, Maher EJ, Lindenbaum RH, Hoogwerf AM, Redman C, Crocker M. Maternal 3;13 chromosome insertion, with severe preeclampsia. Clin Genet 1995; 47:17-21.
50. Heydanus R, Defoort P, Dhont M. Preeclampsia and trisomy 13. Eur J Obstet Gynecol Reprod Biol 1995; 60:201-202.
51. Pedersen BW, Grønlund A. Severe preeclampsia and fetal trisomy 13 in a multiparous woman. Ugeskr Laeger 2003; 165:2108-2109. (Pubitemid 38089446)
52. Kakigano A, Mimura K, Kanagawa T, Nakayama M, Kanayama T, Fujita S, et al. Imbalance of angiogenic factors and avascular edematous cystic villi in a trisomy 13 pregnancy: A case report. Placenta 2013; 34:628-630.
53. Chen CP. Placental abnormalities and preeclampsia in trisomy 13 pregnancies. Taiwan J Obstet Gynecol 2009; 48:3-8.
54. Mueller MD, Brühwiler H. HELLP syndrome and trisomy 18 in a multiparity patient. Z Geburtshilfe Neonatol 1996; 200:119-121. (Pubitemid 26261201)
55. Wilson ML, Brueggmann D, Desmond DH, Mandeville JE, Goodwin TM, Ingles SA. A fetal variant in the GCM1 gene is associated with pregnancy induced hypertension in a predominantly Hispanic population. Int J Mol Epidemiol Genet 2011; 2:196-206.
56. Baczyk D, Kibschull M, Mellstrom B, Levytska K, Rivas M, Drewlo S, et al. DREAM mediated regulation of GCM1 in the human placental trophoblast. PLoS One 2013; 8:e51837.
57. Wilson ML, Desmond DH, Goodwin TM, Miller DA, Ingles SA. Maternal and fetal variants in the TGF-beta3 gene and risk of pregnancy-induced hypertension in a predominantly Latino population. Am J Obstet Gynecol 2009; 201:295.e1-295.e5.
58. Caniggia I, Grisaru-Gravnosky S, Kuliszewsky M, Post M, Lye SJ. Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J Clin Invest 1999; 103:1641-1650. (Pubitemid 29534358)
59. Xiang P, Li Z, Di H, Nie S, Yan W. The associations between maternal and fetal angiotensinogen M235T polymorphism and pregnancyinduced hypertension in Chinese women. Reprod Sci 2011; 18:640-644.
60. Hill LD, Hilliard DD, York TP, Srinivas S, Kusanovic JP, Gomez R, et al. Fetal ERAP2 variation is associated with preeclampsia in African Americans in a case-control study. BMC Med Genet 2011; 12:64.
61. Zhou A, Dekker GA, Lumbers ER, Lee SY, Thompson SD, McCowan LM, et al. The association of AGTR2 polymorphisms with preeclampsia and uterine artery bilateral notching is modulated by maternal BMI. Placenta 2013; 34:75-81.
62. Andraweera PH, Dekker GA, Thompson SD, Roberts CT. Singlenucleotide polymorphisms in the KDR gene in pregnancies complicated by gestational hypertensive disorders and small-for-gestationalage infants. Reprod Sci 2012; 19:547-554.
63. Tan CY, Ho JF, Chong YS, Loganath A, Chan YH, Ravichandran J, et al. Paternal contribution of HLA-G-0106 significantly increases risk for preeclampsia in multigravid pregnancies. Mol Hum Reprod 2008; 14:317-324.
64. Kanayama N, Takahashi K, Matsuura T, Sugimura M, Kobayashi T, Moniwa N, et al. Deficiency in p57Kip2 expression induces preeclampsia-like symptoms in mice. Mol Hum Reprod 2002; 8:1129-1135. (Pubitemid 36032852)
65. Falcao S, Solomon C, Monat C, Bérubé J, Gutkowska J, Lavoie JL. Impact of diet and stress on the development of preeclampsia-like symptoms in p57kip2 mice. Am J Physiol Heart Circ Physiol 2009; 296:H119-H126.
66. Redline RW, Patterson P. Preeclampsia is associated with an excess of proliferative immature intermediate trophoblast. Hum Pathol 1995; 26:594-600.
67. Petry CJ, Evans ML, Wingate DL, Ong KK, Reik W, Constância M, et al. Raised late pregnancy glucose concentrations in mice carrying pups with targeted disruption of H19delta13. Diabetes 2010; 59:282-286.
68. Petry CJ, Seear RV, Wingate DL, Manico L, Acerini CL, Ong KK, et al. Associations between paternally transmitted fetal IGF2 variants and maternal circulating glucose concentrations in pregnancy. Diabetes 2011; 60:3090-3096.
69. The Hyperglycemia Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: preeclampsia. Am J Obstet Gynecol 2010; 202:255.e1-255.e7.
70. Bainbridge SA, Minhas A, Whiteley KJ, Qu D, Sled JG, Kingdom JC, et al. Effects of reduced Gcm1 expression on trophoblast morphology, fetoplacental vascularity, and pregnancy outcomes in mice. Hypertension 2012; 59:732-739.
71. Chen CP, Chen CY, Yang YC, Su TH, Chen H. Decreased placental GCM1 (glial cells missing) gene expression in preeclampsia. Placenta 2004; 25:413-421. (Pubitemid 38519115)
72. Doridot L, Passet B, Méhats C, Rigourd V, Barbaux S, Ducat A, et al. Preeclampsia-like symptoms induced in mice by fetoplacental expression of STOX1 are reversed by aspirin treatment. Hypertension 2013; 61:662-668.
73. van Dijk M, Oudejans CB. STOX1: key player in trophoblast dysfunction underlying early onset preeclampsia with growth retardation. J Pregnancy 2011; 2011:521826.
74. van Dijk M, van Bezu J, van Abel D, Dunk C, Blankenstein MA, Oudejans CB, et al. The STOX1 genotype associated with preeclampsia leads to a reduction of trophoblast invasion by alpha-T-catenin upregulation. Hum Mol Genet 2010; 19:2658-2667.
75. Takimoto E, Ishida J, Sugiyama F, Horiguchi H, Murakami K, Fukamizu A. Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science 1996; 274:995-998. (Pubitemid 26398424)
76. Rigó J Jr, Boze T, Derzsy Z, Derzbach L, Treszl A, Lázár L, et al. Family history of early-onset cardiovascular disorders is associated with a higher risk of severe preeclampsia. Eur J Obstet Gynecol Reprod Biol 2006; 128:148-151. (Pubitemid 44322021)
77. Myklestad K, Vatten LJ, Salvesen KA, Davey Smith G, Romundstad PR. Hypertensive disorders in pregnancy and paternal cardiovascular risk: A population-based study. Ann Epidemiol 2011; 21:407-412.
78. Pfab T, Chen YP, Slowinski T, Richter CM, Godes M, Arck PC, et al. Impact of genes related to immune tolerance and inflammation (tumour necrosis factor-alpha, interleukin-6) on blood pressure, protein excretion and oedema in pregnancy. J Hypertens 2005; 23:2187-2191. (Pubitemid 41666748)
79. Triche EW, Harland KK, Field EH, Rubenstein LM, Saftlas AF. Maternal-fetal HLA sharing and preeclampsia: variation in effects by seminal fluid exposure in a case-control study of nulliparous women in Iowa. J Reprod Immunol 2014; 101:111-119.
80. Hiby SE, Walker JJ, O'Shaughnessy KM, Redman CW, Carrington M, Trowsdale J, Moffett A. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004; 200:957-965. (Pubitemid 39431121)
81. Saito S, Takeda Y, Sakai M, Nakabayahi M, Hayakawa S. The incidence of preeclampsia among couples consisting of Japanese women and Caucasian men. J Reprod Immunol 2006; 70:93-98. (Pubitemid 43669092)
82. Caughey AB, Stotland NE, Washington AE, Escobar GJ. Maternal ethnicity, paternal ethnicity, and parental ethnic discordance: predictors of preeclampsia. Obstet Gynecol 2005; 106:156-161. (Pubitemid 40898449)
83. Moffett A, Hiby S, Carrington M. The incidence of preeclampsia among couples consisting of Japanese women and Caucasian men (letter). J Reprod Immunol 2006; 71:132-133.
84. Saito S, Sakai M. The incidence of preeclampsia among couples consisting of Japanese women and Caucasian men (letter). J Reprod Immunol 2006; 71:134.
85. Robillard PY, Dekker G, Chaouat G, Hulsey TC, Saftlas A. Epidemiological studies on primipaternity and immunology in preeclampsia: A statement after twelve years of workshops. J Reprod Immunol 2011; 89:104-117.
86. Xiong X, Demianczuk NN, Buekens P, Saunders LD. Association of preeclampsia with high birth weight for age. Am J Obstet Gynecol 2000; 183:148-155. (Pubitemid 30626042)
87. Luo ZC, Simonet F, An N, Bao FY, Audibert F, Fraser WD. Effect on neonatal outcomes in gestational hypertension in twin compared with singleton pregnancies. Obstet Gynecol 2006; 108:1138-1144. (Pubitemid 44665408)
88. Stella CL, O'Brien JM, Forrester KJ, Barton JR, Istwan N, Rhea D, et al. The coexistence of gestational hypertension and diabetes: influence on pregnancy outcome. Am J Perinatol 2008; 25:325-329.
89. Naeye RL. Maternal blood pressure and fetal growth. Am J Obstet Gynecol 1981; 141:780-787. (Pubitemid 12237440)
90. Steer PJ, Little MP, Kold-Jensen T, Chapple J, Elliott P. Maternal blood pressure in pregnancy, birth weight, and perinatal mortality in first births: prospective study. BMJ 2004; 329:1312.
91. Bakker R, Steegers EA, Hofman A, Jaddoe VW. Blood pressure in different gestational trimesters, fetal growth, and the risk of adverse birth outcomes: The generation R study. Am J Epidemiol 2011; 174:797-806.
92. Kawafuji A, Suda N, Ichikawa N, Kakara S, Suzuki T, Baba Y, et al. Systemic and maxillofacial characteristics of patients with Beckwith-Wiedemann syndrome not treated with glossectomy. Am J Orthod Dentofacial Orthop 2011; 139:517-525.
93. Nielsen EM, Hansen L, Stissing T, Yanagisawa K, Borch-Johnsen K, Poulsen P, et al. Studies of variations of the cyclin-dependent kinase inhibitor 1C and the cyclin-dependent kinase 4 genes in relation to type 2 diabetes mellitus and related quantitative traits. J Mol Med (Berl) 2005; 83:353-361. (Pubitemid 41201800)
94. Tunster SJ, Van de Pette M, John RM. Fetal overgrowth in the Cdkn1c mouse model of Beckwith-Wiedemann syndrome. Dis Model Mech 2011; 4:814-821.
95. Murrell A, Heeson S, Cooper WN, Douglas E, Apostolidou S, Moore GE, et al. An association between variants in the IGF2 gene and Beckwith-Wiedemann syndrome: interaction between genotype and epigenotype. Hum Mol Genet 2004; 13:247-255. (Pubitemid 38111362)
96. Dunger DB, Petry CJ, Ong KK. Genetics of size at birth. Diabetes Care 2007; 30 (suppl 2):S150-S155. (Pubitemid 47036418)
97. Myrelid A, Gustafsson J, Ollars B, Annerén G. Growth charts for Down's syndrome from birth to 18 years of age. Arch Dis Child 2002; 87:97-103. (Pubitemid 34828010)
98. Bahado-Singh RO, Lynch L, Deren O, Morroti R, Copel JA, et al. Firsttrimester growth restriction and fetal aneuploidy: The effect of type of aneuploidy and gestational age. Am J Obstet Gynecol 1997; 176:976-980. (Pubitemid 27227505)
99. Boghossian NS, Horbar JD, Murray JC, Carpenter JH, Vermont Oxford Network. Anthropometric charts for infants with trisomies 21, 18, or 13 born between 22 weeks gestation and term: The VON charts. Am J Med Genet A 2012; 158A:322-332.
100. Schlemm L, Haumann HM, Ziegner M, Stirnberg B, Sohn A, Alter M, et al. New evidence for the fetal insulin hypothesis: fetal angiotensinogen M235T polymorphism is associated with birth weight and elevated fetal total glycated hemoglobin at birth. J Hypertens 2010; 28:732-739.
101. Pfab T, Stirnberg B, Sohn A, Krause K, Slowinski T, Godes M, et al. Impact of maternal angiotensinogen M235T polymorphism and angiotensin-converting enzyme insertion/deletion polymorphism on blood pressure, protein excretion and fetal outcome in pregnancy. J Hypertens 2007; 25:1255-1261. (Pubitemid 46918805)
102. Abu-Amero S, Monk D, Apostolidou S, Stanier P, Moore G. Imprinted genes and their role in human fetal growth. Cytogenet Genome Res 2006; 113:262-270.
103. Frost JM, Moore GE. The importance of imprinting in the human placenta. PLoS Genet 2010; 6:e1001015.
104. Haig D, Westoby M. Parent-specific gene expression and the triploid endosperm. Am Nat 1989; 134:147-155.
105. Trivers RL. Parent-offspring conflict. Amer Zool 1974; 14:249-264.
106. Haig D. Genetic conflicts in human pregnancy. Q Rev Biol 1993; 68:495-553.
107. Reik W, Constância M, Fowden A, Anderson N, Dean W, Ferguson-Smith A, et al. Regulation of supply and demand for maternal nutrients in mammals by imprinted genes. J Physiol 2003; 547:35-44. (Pubitemid 36285159)
108. Haig D. Placental hormones, genomic imprinting, and maternal-foetal communication. J Evol Biol 1996; 9:357-380. (Pubitemid 126617133)
109. Petry CJ. Gestational diabetes: risk factors and recent advances in its genetics and treatment. Br J Nutr 2010; 104:775-787.
110. Hollegaard B, Byars SG, Lykke J, Boomsma JJ. Parent-offspring conflict and the persistence of pregnancy-induced hypertension in modern humans. PLoS One 2013; 8:e56821.